These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 1681710)
1. Differential susceptibility of a rat glioma cell line and its clones to herpes simplex virus types 1 and 2. Sakihama K; Eizuru Y; Minamishima Y Acta Virol; 1991 Apr; 35(2):127-34. PubMed ID: 1681710 [TBL] [Abstract][Full Text] [Related]
2. Studies on interactions of dTK-HSV mutants with neurons in vitro. Veerisetty V; Gentry GA; Veerisetty IK; North ER Acta Virol; 1986 Jan; 30(1):1-9. PubMed ID: 2871727 [TBL] [Abstract][Full Text] [Related]
3. Interaction of herpes simplex virus type 2 with a rat glioma cell line. Sakihama K; Eizuru Y; Minamishima Y Microbiol Immunol; 1988; 32(9):933-47. PubMed ID: 2850449 [TBL] [Abstract][Full Text] [Related]
4. Reproduction in unadapted and adapted cells at 40 degrees C of herpes simplex virus type 1 and type 2 strains. Szántó J Acta Virol; 1975 Jul; 19(4):287-92. PubMed ID: 241225 [TBL] [Abstract][Full Text] [Related]
5. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities. Yasukawa M; Zarling JM J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243 [TBL] [Abstract][Full Text] [Related]
6. [Synergistic effect of all-trans retinoic acid and herpes simplex virus thymidine kinase gene on glioma]. Zhang XF; Ren ZY; Fang FD; Zuo J; Su CB; Wang RZ; Ma WB Ai Zheng; 2002 May; 21(5):473-9. PubMed ID: 12452035 [TBL] [Abstract][Full Text] [Related]
7. Increased susceptibility to infection with herpes simplex virus types 1 and 2 of cold-adapted L cells. Szántó J; Holecková E Acta Virol; 1978 Mar; 22(2):113-22. PubMed ID: 26196 [TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of newborn murine retinal cells to herpes simplex virus type 1 infection. Merges MJ; Whittum-Hudson JA Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1224-30. PubMed ID: 2163995 [TBL] [Abstract][Full Text] [Related]
9. Effects of differentiation of human macrophage-like U937 cells on intrinsic resistance to herpes simplex virus type 1. Tenney DJ; Morahan PS J Immunol; 1987 Nov; 139(9):3076-83. PubMed ID: 2822803 [TBL] [Abstract][Full Text] [Related]
10. Replication of herpes simplex virus in two cell systems derived from rhesus monkeys. Yamada M Biken J; 1983 Mar; 26(1):35-47. PubMed ID: 6312959 [TBL] [Abstract][Full Text] [Related]
11. Effect of hexamethylene bisacetamide and cyclosporin A on recovery of herpes simplex virus type 2 from the in vitro model of latency in a human neuroblastoma cell line. Kondo Y; Yura Y; Iga H; Yanagawa T; Yoshida H; Furumoto N; Sato M Cancer Res; 1990 Dec; 50(24):7852-7. PubMed ID: 2174735 [TBL] [Abstract][Full Text] [Related]
12. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Warner MS; Geraghty RJ; Martinez WM; Montgomery RI; Whitbeck JC; Xu R; Eisenberg RJ; Cohen GH; Spear PG Virology; 1998 Jun; 246(1):179-89. PubMed ID: 9657005 [TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene. Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092 [TBL] [Abstract][Full Text] [Related]
14. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239 [TBL] [Abstract][Full Text] [Related]
15. Regulation of persistent infection with herpes simplex virus in vitro by hydrocortisone. Nishiyama Y; Rapp F J Virol; 1979 Sep; 31(3):841-4. PubMed ID: 229255 [TBL] [Abstract][Full Text] [Related]
16. Abortive infection of neural cells by herpes simplex virus type 2. Smith CA; Lancz GJ Arch Virol; 1982; 74(4):311-23. PubMed ID: 6299239 [TBL] [Abstract][Full Text] [Related]
17. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants. Bishop GA; Marlin SD; Schwartz SA; Glorioso JC J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of herpes simplex virus replication by tobacco extracts. Hirsch JM; Svennerholm B; Vahlne A Cancer Res; 1984 May; 44(5):1991-7. PubMed ID: 6324994 [TBL] [Abstract][Full Text] [Related]
19. A herpes simplex virus type 1 mutant deleted for gamma34.5 and LAT kills glioma cells in vitro and is inhibited for in vivo reactivation. Samoto K; Perng GC; Ehtesham M; Liu Y; Wechsler SL; Nesburn AB; Black KL; Yu JS Cancer Gene Ther; 2001 Apr; 8(4):269-77. PubMed ID: 11393279 [TBL] [Abstract][Full Text] [Related]
20. Calcium ionophore A-23187 and 12-O-tetradecanoyl-phorbol-13-acetate stimulation of prostaglandin synthesis in herpes simplex virus type 2-transformed rat cells. Kucera LS; Iyer N; King L; Krebs C; Waite BM Cancer Res; 1984 Apr; 44(4):1625-9. PubMed ID: 6322982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]